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 2 
Abstract 22 
Poly(methylvinylether-co-maleic acid) (PMVE/MA) is commonly used as a 23 
component of pharmaceutical platforms, principally to enhance interactions with 24 
biological substrates (mucoadhesion).  However, the limited knowledge on the 25 
rheological properties of this polymer and their relationships with mucoadhesion has 26 
negated the biomedical use of this polymer as a mono-component platform. This 27 
study presents a comprehensive study of the rheological properties of aqueous 28 
PMVE/MA platforms and defines their relationships with mucoadhesion using 29 
multiple regression analysis.  Using dilute solution viscometry the intrinsic viscosities 30 
of un-neutralised PMVE/MA and PMVE/MA neutralised using NaOH or TEA were 31 
22.32 ± 0.89 dL g-1, 274.80 ± 1.94 dL g-1 and 416.49 ± 2.21 dL g-1 illustrating greater 32 
polymer chain expansion following neutralisation using Triethylamine (TEA). 33 
PMVE/MA platforms exhibited shear-thinning properties.  Increasing polymer 34 
concentration increased the consistencies, zero shear rate (ZSR) viscosities 35 
(determined from flow rheometry), storage and loss moduli, dynamic viscosities 36 
(defined using oscillatory analysis) and mucoadhesive properties, yet decreased the 37 
loss tangents of the neutralised polymer platforms.  TEA neutralised systems 38 
possessed significantly and substantially greater consistencies, ZSR and dynamic 39 
viscosities, storage and loss moduli, mucoadhesion and lower loss tangents than 40 
their NaOH counterparts.  Multiple regression analysis enabled identification of the 41 
dominant role of polymer viscoelasticity on mucoadhesion (r>0.98). The 42 
mucoadhesive properties of PMVE/MA platforms were considerable and were 43 
greater than those of other platforms that have successfully been shown to enhance 44 
in vivo retention when applied to the oral cavity, indicating a positive role for 45 
PMVE/MA mono-component platforms for pharmaceutical and biomedical 46 
applications.    47 
 3 
1. Introduction 48 
Poly (methylvinylether-co-maleic anhydride) is a 1:1 copolymer of methyl vinyl ether 49 
and maleic anhydride that is available in various grades, including the free acid form, 50 
poly (methyl vinyl ether-co-maleic acid) (PMVE/MA)[1].  The low toxicity and 51 
excellent biocompatibility of PMVE/MA have resulted in its widespread use 52 
throughout the pharmaceutical and cosmetic industry[2, 3]. In particular, this 53 
polymer has found use within toothpastes, mouthwashes, denture adhesives, 54 
hairsprays, transdermal patches, periodontal drug delivery systems and within 55 
stoma adhesive pastes[4-8].  56 
 57 
PMVE/MA has been reported to form adhesive interactions with mucin-coated 58 
epithelial surfaces (termed mucoadhesion)[9-11] and, as a result, has been used as 59 
a component of a range of biomedical implants where retention at the site of 60 
application is important, e.g. as mucoadhesive nanospheres and microspheres, 61 
mucoadhesive buccal tablets, mucoadhesive implants for application to the 62 
periodontal pocket and microneedle transdermal systems.   In such applications 63 
mucoadhesion has been shown to enhance the retention of the implant at the site of 64 
application, thereby facilitating controlled drug release and offering site specific 65 
mechanical properties[6, 9, 12, 13].  The mucoadhesive properties of PMVE/MA are 66 
accredited to its large molecular weight, its favourable chemical functional groups 67 
and anionic charge, all of which aid interaction with the mucus layer through 68 
polymer mucin interpenetration and the formation of various hydrogen bridges[9, 14, 69 
15].  70 
 71 
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The successful pharmaceutical and biomedical applications of PMVE/MA have 72 
predominantly required the formation of networks with other polymers, most notably 73 
poly(vinylpyrrolidone, PVP).  For example in a series of publications, Jones et al. 74 
described the formulation of networks of PMVE/MA and PVP that were designed for 75 
use as implants within the oral cavity[6, 12, 13].  In these studies it was shown that 76 
the rheological properties of the networks were engineered through modification of 77 
both the ratio of PMVE/MA to PVP and polymer concentration.  Other studies have 78 
described the design of biomedical implants that involve the use of PMVE/MA in 79 
association with other polymers.  For example, Moreno et al. described the 80 
formulation of thermosensitive hydrogels of PMVE/MA and Pluronic F127 that were 81 
designed for the controlled release of proteins[16]. Whereas the combined use of 82 
PMVE/MA and poloxamer 407 and hydroxypropylcellulose gels designed for the 83 
treatment of oropharyngeal cancer has been described[17].  Most recently however 84 
Jones et al. highlighted a significant concern regarding the use of interactive 85 
polymer networks involving PMVE/MA.  The combination of PMVE/MA and 86 
poly(vinyl alcohol) produced rheologically structured, mucoadhesive networks.  87 
However, upon storage, the viscoelastic and mucoadhesive properties of the 88 
networks were observed to significantly and detrimentally change thereby obviating 89 
their use as biomedical implants.  Conversely, there was no alteration of the 90 
rheological properties of mono-polymeric PMVE/MA systems on storage [18].  The 91 
use of binary polymeric networks involving PMVE/MA must therefore be treated with 92 
extreme caution. 93 
 94 
Despite the (growing) number of publications that describe the use of PMVE/MA-95 
based platforms for biomedical applications (particularly for drug delivery 96 
applications), there is a paucity of studies that have examined the physicochemical 97 
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properties of PMVE/MA regarding its suitability as a monopolymeric platform for 98 
biomedical applications.  This oversight is of scientific relevance for two reasons.  99 
Firstly, without an understanding of the rheological and mucoadhesive properties of 100 
PMVE/MA, the formulation of existing biomedical implants may not be optimal, with 101 
detrimental consequences on their clinical usage.  Secondly, full understanding and 102 
knowledge of the rheological and mucoadhesive properties will offer possibilities for 103 
the use of this polymer for an enhanced range of applications, e.g. as 104 
pharmaceutical implants, drug delivery applications and as mucoadhesive, 105 
viscoelastic implants designed to facilitate cataract removal[19]. 106 
 107 
Therefore, this study aims to provide a comprehensive description of the rheological 108 
properties of PMVE/MA and, for the first time, to specifically statistically examine the 109 
relationship of these properties to the mucoadhesive properties.  In particular the 110 
generated data and the relationships between the various rheological and 111 
mucoadhesive properties will be statistically modelled, thereby providing a 112 
comprehensive characterisation of the relationship between these parameters.  In 113 
so doing this study will offer a beneficial insight into the potential biomedical 114 
applications of PMVE/MA and of the contribution of physicochemical properties of 115 
PMVE/MA to mucoadhesion, an area as yet not fully clarified. 116 
  117 
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2. Materials and Methods 118 
2.1 Materials 119 
Poly(methylvinylether-co-maleic acid, PMVE/MA) (Gantrez® SBF97) with an average 120 
molecular weight of approximately 1,200,000 Da was kindly donated by ISP, Surrey, 121 
UK.  Sodium hydroxide (NaOH) pellets and triethylamine (TEA) were purchased from 122 
Sigma Aldrich, Dorset, England.  All other chemicals were purchased from BDH 123 
Laboratory supplies Dorset, England and were of AnalaR grade, or equivalent quality. 124 
 125 
2.2. Methods 126 
2.2.1  Manufacture of Dilute PMVE/MA Solutions 127 
Stock solutions (0.2-0.6 g/dl) of PMVE/MA were prepared by adding the required 128 
mass of polymer to an appropriate volume of deionised water (pH 5.0-5.2). The 129 
polymeric solutions (five replicate batches) were subsequently agitated using a 130 
mechanical stirrer. Dilution of stock solutions was carried out to obtain the desired 131 
concentration, with the final volume being corrected after neutralisation of the 132 
relevant systems. Neutralisation of suitable solutions was carried out via the drop 133 
wise addition of sodium hydroxide solution (30% w/w NaOH) or Triethylamine (TEA) 134 
until a pH value of 7.4 was obtained (measured using a Hanna Instruments pH 135 
meter). The solutions examined reflected a range of un-neutralised, TEA and NaOH 136 
neutralised PMVE/MA systems.  137 
 138 
 139 
 140 
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2.2.2.  Manufacture of Bulk Aqueous PMVE/MA Systems. 141 
PMVE/MA systems were manufactured via the slow addition of the appropriate 142 
amount of polymer (5-30% w/w) to deionised water under mechanical mixing via a 143 
mechanical stirrer. A number of gels had their pH adjusted to pH 7.4 using either a 144 
30% w/w NaOH solution or TEA; with gel pH determined using a flat faced gel pH 145 
probe. To remove air, all samples were stored for 24hrs prior to testing, with all 146 
testing being completed within a 72hr period. Bulk rheological measurements were 147 
performed using both continuous shear analysis and oscillatory analysis. 148 
 149 
2.2.3.  Viscometric Analysis of Dilute Solutions.  150 
All viscometric analyses of PMVE/MA solutions (0.2-0.6 g/dl) were performed using 151 
Rheotek Ostwald U-tube viscometers sizes O-D. Solutions were added to the tube 152 
via a pipette until the required level was reached. The U-tube was then placed into a 153 
Rheotek water bath pre-set to 37°C±0.5°C and allowed to equilibrate for 15 minutes.  154 
The time required for the fluid to fall a predetermined distance was measured and 155 
used to calculate the kinematic viscosity (υ, mm2s-1) (Equation 1). 156 
𝜐 = 𝑘𝑡          Equation 1 157 
where: k refers to the U-tube multiplication factor and t refers the solution/solvent 158 
flow time (sec) 159 
From this the relative viscosity (𝜂&'() was calculated  160 
𝜂&'( = 	 **+            Equation 2 161 
Where: 𝜐 and 𝜐, refer to the kinematic viscosities of the polymeric solution and the 162 
solvent in which the polymer is dispersed, respectively. 163 
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The specific viscosity (𝜂-.) is then calculated:  164 
𝜂-. = 	 𝜂&'( − 1           Equation 3 165 
The reduced viscosity (ηred) may be thus expressed as the ratio of the specific 166 
viscosity to the concentration: 167 
𝜂&'1 = 	 2345            Equation 4 168 
Where C is the concentration of the polymer in g/dl[20].  169 
 170 
U-tubes were chosen so that the efflux time for each solution was always above 200 171 
sec (or 300 seconds for the O size tube) thus allowing greater accuracy within 172 
measured results. The viscometric properties of five replicate solutions were 173 
measured in all cases. 174 
 175 
Calculation of the intrinsic viscosity of each system [𝜂] was performed using the 176 
Huggin’s equation (equation 5) or the equation described by Fuoss and Strauss 177 
(equation 6)[21] [22, 23]. 178 
𝜂&'1 = 	 2345 = 𝜂 +	𝑘7[𝜂]:𝐶       Equation 5 179 
Where (in addition to the previous descriptions) C is the polymer concentration and 180 
k’ refers to Huggin’s constant 181 
𝜂-. = 	 [2]<=> 5          Equation 6 182 
Where:  C is the polymer concentration and B is a constant 183 
 184 
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2.2.4.  Continuous Shear Analysis. 185 
Continuous shear (flow) analyses were performed at 37°C on the PMVE/MA (5-30% 186 
w/w) systems using a TA systems AR2000 rheometer. Flow rheograms were 187 
determined using either a 6cm or 4cm parallel stainless steel plate (gap size 1000 188 
µm), the choice of geometry being determined by sample consistency. Samples to 189 
be analysed were applied to the lower plate and allowed 15 minutes to equilibrate to 190 
negate any stresses induced during sample application. The shear stress was 191 
applied over a predetermined range, with this range again being determined by 192 
sample consistency. Mathematical modelling of the flow properties of the various 193 
polymeric platforms was performed using the Rheology Advantage software (TA 194 
Instruments) in conjunction with the Ostwald-de-Waele power law model (equation 195 
7)[24] and the Cross model (equation 8)[25], as follows: 196 
𝜎 = 𝑘𝛾A         Equation 7 197 
Where: 𝜎  refers to the shear stress, 𝛾  refers to the rate of shear, k refers to the 198 
consistency and n represents a power law index 199 
𝜂 = 	 𝜂B +	 2+C	2D<=	(FG)I         Equation 8 200 
Where: η is viscosity, η∞ is the infinite shear viscosity, K is a structural relaxation 201 
time, m is dimensionless and η0 is the zero rate viscosity.   202 
In each case, the flow properties of at least five replicates were determined. 203 
 204 
2.2.5.  Oscillatory Analysis. 205 
Oscillatory analyses were performed at 37°C on PMVE/MA (5-30% w/w) systems 206 
using a TA systems AR2000 rheometer, as previously reported by the authors[26]. 207 
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Rheological analyses were conducted using either a 6cm or 4cm parallel stainless 208 
steel plate (gap size 1000 µm); the choice of geometry was determined by sample 209 
consistency. Samples to be analysed were applied to the lower plate and allowed 210 
15 minutes to equilibrate to negate any stresses induced during sample application. 211 
For each sample, the linear viscoelastic region was determined via a stress sweep at 212 
a fixed frequency. Once determined, a frequency sweep from 0.1 to 10Hz was 213 
performed at a stress value selected from within the linear viscoelastic region. The 214 
linear viscoelastic region was identified as the region in which the stress and the 215 
strain were directly proportional and where the storage modulus (G`) remained 216 
constant. From the resulting relationships between modulus and oscillatory 217 
frequency, the storage modulus (G’), loss modulus (G”), dynamic viscosity (η’) and 218 
the loss tangent (tan δ) were then determined using the Rheology Advantage 219 
software provided by T.A. Instruments. In each case the dynamic rheological 220 
properties of at least five replicates were determined.  221 
 222 
2.2.6.  Mucoadhesion Testing 223 
Mucoadhesion testing was conducted using a TA XT2 Texture Analyser in adhesion 224 
mode as previously reported by Jones et al.[27-29]. In brief, 400mg mucin discs 225 
were manufactured using a 13mm IR press using a force of 10 tonnes for a period of 226 
one minute. The discs were then attached to the end of a 10mm diameter 227 
polycarbonate probe via double sided adhesive tape. Samples to be analysed were 228 
transferred into a three-sided mould with mucoadhesion testing being determined at 229 
37oC. Prior to testing, samples were stored in sealed sample vials incubated at 37oC 230 
for 24hrs. Before testing, the disc was pre-wetted with 5% mucin solution with 231 
excess being removed via blotting.  A downward force of 0.1N was applied to the 232 
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polymer platform, held for 30 seconds before being removed at a speed of 10mms-1. 233 
Mucoadhesion, determined as the force required to detach the polymer platform 234 
from the mucin disc, of each formulation was obtained from five replicates 235 
measurements.  236 
 237 
2.2.7. Statistical Analysis 238 
Statistical modelling was performed using a General Linear Model.  The effects of 239 
polymer concentration, type of pH neutralising agent and oscillatory frequency on 240 
the viscoelastic properties (storage modulus, loss modulus, tan δ and dynamic 241 
viscosity (η’) were statistically examined using a two-way repeated measures 242 
Analysis of Variance.  The effects of polymer concentration and type of pH 243 
neutralising agent on the gel strength, rheological exponent and on crossover 244 
frequency were statistically examined using a two-way Analysis of Variance.  The 245 
effects of neutralising agent on the intrinsic viscosity and critical concentration (C*) 246 
of PMVE/MA was statistically analysed using a one way ANOVA.  Post-hoc analysis 247 
of individual treatment differences was performed using Tukey’s HSD test.  In all 248 
cases p<0.05 was accepted as denoting significance and therefore the individual 249 
probability values have not been included in the text. 250 
 251 
Statistical modelling of the relationship between polymer concentration and the type 252 
of neutralising agent on the viscoelastic parameters (at three defined frequencies, 253 
2.37, 5.39 and 9.99Hz) and on mucoadhesion was performed using a multiple linear 254 
regression model (two-way ANOVA).  As before, post-hoc analysis of individual 255 
treatment differences was performed using Tukey’s HSD test (p<0.05 denoting 256 
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significance).  The relationships between viscoelastic properties (G’, G’’, tan δ and 257 
η’) and mucoadhesion were examined using multiple correlation analysis. 258 
 259 
In all cases measurements and statistical analyses were performed on five replicate 260 
samples (n = 5). 261 
 262 
263 
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 3. Results and Discussion 264 
Mucoadhesive polymers have been extensively used within the pharmaceutical 265 
industry, finding use within a wide range of formulations such as eye drops, vaginal 266 
gels, nasal inserts, buccal tablets and with some limited success in peroral drug 267 
delivery[9].  PMVE/MA has been reported to have strong mucoadhesive properties[8, 268 
9, 30] however, this polymer has been limited to a component within implants that 269 
contain other polymeric systems.  Whilst theoretically this strategy may have merit, 270 
the authors have recently reported that PMVE/MA networks may undergo 271 
rheological ageing, resulting in compromised rheological and mucoadhesive 272 
properties[18].  There are therefore concerns regarding this strategy.  There has 273 
been a distinct paucity of reports that have examined the mucoadhesive properties 274 
and additionally the rheological properties of PMVE/MA monopolymeric systems.  275 
Furthermore, this manuscript has addressed a major deficiency in the scientific 276 
literature, namely the contribution of polymer viscoelasticity to mucoadhesion, a 277 
relationship that requires full understanding to enable the rational design of 278 
mucoadhesive systems as biomedical implants. 279 
 280 
3.1. Dilute Solution Properties of PMVE/MA 281 
In this study the intrinsic viscosities of PMVE/MA dilute solutions, (un-neutralised or 282 
neutralised using NaOH or TEA) were determined via extrapolation of the Huggins or 283 
the Fuoss and Strauss plots (Figures 1a and 1b, respectively).  Modelling of the 284 
mathematical relationships revealed that the plot of reduced viscosity against 285 
concentration of PMVE/VA for neutralised systems was non-linear thereby 286 
invalidating the use of the Huggins model to determine intrinsic viscosity of these 287 
systems.  Notably, the reduced viscosity was observed to decrease with increasing 288 
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concentration of polymer in a manner typical of polyelectrolyte solutions[31].  Fuoss 289 
and Strauss[32, 33] reported an empirical expression from which the intrinsic 290 
viscosity of polyelectrolytes may be determined from the linear plot of the reciprocal 291 
of reduced viscosity against polymer concentration0.5.  Using this relationship, the 292 
intrinsic viscosities of un-neutralised PMVE/MA and PMVE/MA neutralised using 293 
NaOH or TEA were 22.32 ± 0.89 dL g-1, 274.80 ± 1.94 dL g-1 and 416.49 ± 2.21 dL g-294 
1, respectively and were significantly different.  Plotting the relationship between 295 
log10 specific viscosity and log10 polymer concentration provides a further 296 
understanding of the dilute solution properties of PMVE/MA.  PMVE/MA solutions 297 
that had been neutralised using NaOH or TEA exhibited statistically significant 298 
inflection points (C*) at PMVE/MA concentrations of 0.26 ± 0.01 and 0.28 ± 0.01 g 299 
dl-1, respectively.   No inflection point was observed for un-neutralised systems.  300 
Below the critical overlap concentration (C*) within a polymer network, polymer 301 
chains exist independently as single units without entanglement. At this dilute 302 
concentration, association of polymer chains is negligible allowing analysis of the 303 
polymer chain conformation[34]. It is this polymer chain conformation that eventually 304 
influences the various topological constraints and supramolecular organisations that 305 
will occur within a network eventually giving rise to gel formation[35].  The intrinsic 306 
viscosity of a polymer represents the hydrodynamic volume which an individual 307 
polymer chain occupies, thereby reflecting the dimensions of the polymer chain[36] 308 
and indicates the role of factors, e.g.  polymer/solvent interactions, pH and the 309 
presence of other ions within solutions on gel networks formed from these 310 
systems[37].  In this study the intrinsic viscosity increased following neutralisation 311 
due to the expanded conformation of the polymer chains resultant from ionisation of 312 
the pendant carboxyl acid groups of the polymer.  Hence, when neutralised the 313 
polymer chains are in an expanded conformation occupying a greater spatial 314 
dimension than the compact un-neutralised PVME/MA polymer chains.  The choice 315 
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of neutralising agent was also observed to have a significant effect on the intrinsic 316 
viscosity values of PMVM/MA chains. TEA neutralised systems were observed to 317 
have significantly higher intrinsic viscosities than those obtained via NaOH 318 
neutralisation and hence TEA neutralised chains occupied the greater hydrodynamic 319 
volume.  Variation between the two neutralised polymeric solutions may be 320 
attributed to shielding of these electrostatic charges by sodium ions within solutions 321 
neutralised by NaOH, which restricted polymer chain extension. Ionic strength has 322 
been shown to have a significant effect on polyelectrolyte gels containing 323 
carboxylate groups. Previously Tam and Tiu[38] investigated the effect of various 324 
cations on the rheology of solutions of the anionic polymer polyacrylamide. They 325 
observed that the presence of cations such as Na+ reduced polymer inter and 326 
intramolecular interactions causing a significant reduction in solution viscosity.  327 
 328 
3.2. Flow Properties of PMVE/MA Gels 329 
The effects of polymer concentration, neutralisation and the type of neutralising 330 
agent on the consistency and rate index of PMVE/MA gels, modelled using the 331 
Ostwald-de-Waele power law model and on their zero-shear rate viscosities, 332 
modelled using the Cross model, are shown in Table 1.  Neutralised polymeric 333 
platforms were pseudoplastic, evident from the rate indices being statistically less 334 
than 1.  Increasing polymer concentration and neutralisation of the PMVE/MA 335 
systems significantly decreased the rate index and increased both the consistency 336 
and zero-shear rate viscosities.  Furthermore, the effect of TEA on these properties 337 
was significantly greater than for NaOH.  These observations accounted for a 338 
statistically significant interaction term in the ANOVA, indicative of a non-additive 339 
effect of the various variables.  Hence, the effects of polymer concentration on the 340 
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aforementioned properties were dependent on the pH of the gels and the 341 
neutralising agent.  The observed flow properties of the neutralised gels were 342 
expected, given that the polymer concentrations dramatically exceeded the C* 343 
concentration.  The effect of polymer concentration on the observed flow properties 344 
is due to an increased number of molecular interactions between the polymer 345 
chains[39].  All platforms showed an increase in the zero rate viscosity (i.e. the 346 
viscosity a system would exhibit when at rest) upon increasing polymer 347 
concentration, denoting a stronger network due to increased interaction between 348 
polymer chains[40]. Increases in zero shear rate viscosity were observed to be non-349 
linear in relation to increasing PVM/MA concentrations for all platforms; this being 350 
indicative of increasing interactions between constituent groups within the polymer 351 
chains which are disproportionate to increases in polymer concentration.  The 352 
effects of neutralisation on the flow properties were in accordance with the 353 
observations from dilute solution viscometry, with TEA neutralised systems offering 354 
greater resistance to deformation (increased consistency and zero shear rate 355 
viscosity) than comparator systems neutralised using NaOH.  For example a 25% 356 
w/w TEA neutralised system had a consistency value of 1191.00 ± 11.53 Pa.sn, and 357 
a zero rate viscosity of 3397.67 ± 80.21 Pa.s, whilst a 25% w/w NaOH neutralised 358 
system had values of 510.10 ± 9.20 Pa.sn and 992.97 ± 11.22 Pa.s, respectively. 359 
Thus, electrostatic shielding of ionised carboxylate groups due to the presence of 360 
Na+ ions restricts the extension of the PMVE/MA polymer chain within NaOH 361 
neutralised networks. As a result, the more highly expanded PMVE/MA polymer 362 
chains, present within TEA neutralised formulations, have a greater probability of 363 
entangling with one another thereby forming a more structured network than 364 
typically experienced within similarly concentrated NaOH neutralised formulations. 365 
The addition of small counterions can effectively reduce the mutual charge repulsion 366 
of carboxylate anions resulting in polymer chain coiling[41].  367 
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 368 
3.3. Oscillatory Rheometry of PMVE/MA Gels 369 
The effects of frequency, PMVE/MA concentration and type of neutralisation agent 370 
on the storage and loss moduli of the systems under investigation are graphically 371 
displayed in Figures 2-4.  Furthermore, a summary of the effects of the 372 
aforementioned parameters on the loss tangents and dynamic viscosities at 373 
specified frequencies is presented in Table 2.  The frequency dependence of both 374 
the elastic and loss moduli indicate that the formation of viscoelastic networks are 375 
as a result of non-covalent intermolecular interactions and polymer chain 376 
entanglements[42-44]. Whilst increasing PMVE/MA concentration (in the un-377 
neutralised state) increased the storage and loss moduli and the dynamic viscosity 378 
(at each frequency), the magnitudes of these parameters were small and, 379 
furthermore, the loss tangent exceeded 1 at all concentrations and frequencies 380 
examined. These observations are typical of an elastoviscous system[18].  The 381 
failure to determine an LVR for 5% and 10% w/w PVME/MA un-neutralised 382 
formulations can be directly attributed to their lack of suitable viscoelastic structure. 383 
These results are consistent with the presence of PMVE/MA in the coiled state, with 384 
minimal interactions between adjacent polymer chains[18, 41].  In the neutralised 385 
state, the moduli dramatically increased, complementing the findings from 386 
continuous shear analysis. The storage and loss moduli and dynamic viscosity 387 
exhibited within neutralised systems were significantly higher than those recorded 388 
for un-neutralised formulations, whilst tan δ values were significantly lower. For 389 
example, the storage and loss moduli of a 30% w/w un-neutralised formulation of 390 
PVME/MA were 523.03 ± 25.64 Pa and 633.20 ± 26.82 Pa, respectively, whereas 391 
the storage and loss moduli of the corresponding NaOH neutralised system were 392 
5552.33 ± 134.75 Pa and 3310.00 ± 49.57 Pa (all measured at a frequency of 6.19 393 
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Hz).  As observed previously within viscometric and continuous shear analyses, the 394 
choice of neutralising agent had a significant effect on measured viscoelastic 395 
parameters. TEA neutralised formulations possessed significantly higher elastic and 396 
loss moduli and dynamic viscosity values, whereas tan δ values were observed to 397 
be significantly lower than those of NaOH neutralised systems at comparable 398 
PMVE/MA concentrations and oscillatory frequencies. A 30% PMVE/MA TEA 399 
neutralised formulation had a tan δ value of 0.50 ± 0.01, whereas a 30% w/w 400 
PVM/MA NaOH neutralised formulation presented a significantly higher tan δ value 401 
of 0.57 ± 0.01 (frequency 8.50 Hz). Polyelectrolyte systems are known to be very 402 
sensitive to changes in pH, with neutralisation of acidic groups, as observed in this 403 
study, leading to the formation of a tighter gel network via non-covalent association 404 
of polymer chains[45]. The presence of various ions however can cause shielding of 405 
the negatively charged carboxylate groups resulting in a reduction in the repulsion 406 
between polymer chains, decreasing formulation viscosity and elasticity[46].  The 407 
net effect of this shielding effect that was apparent in this study was gels that had 408 
been neutralised by sodium hydroxide exhibited lower elasticity than their organic 409 
amine neutralised counterparts.  This is apparent from the greater magnitude of the 410 
storage modulus, the lower loss tangent values, the lower gel strength and the lower 411 
crossover frequency of TEA-neutralised PMVE/MA gels, as depicted in Table 3.   412 
This table provides an insight into the frequency dependence of the elastic and loss 413 
moduli through the use of a power law model, which characterises the material 414 
strength (K) and the frequency dependency of the platform (n).  Together, these 415 
parameters provide a further understanding of the nature of the platform under 416 
investigation[47, 48].  Power Law exponent values of moduli were observed to 417 
significantly decrease, whilst moduli gel strength values significantly increased upon 418 
increasing PMVE/MA concentration and/or following neutralisation. These observed 419 
trends indicate the movement towards more structured viscoelastic networks.  An n 420 
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value close to or equal to zero is representative of a covalently crosslinked system, 421 
whereas a network exhibiting an n value greater than zero indicates the presence of 422 
a physical gel network[36].  All Power Law exponent values were markedly greater 423 
than zero, consistent with the properties of polymer-entangled networks. According 424 
to Winter and Chambon[49] a power Law exponent for both moduli equal or less 425 
than 0.5 and where G’>G”, indicates the presence of a gel. Using this principle only 426 
a 30% w/w PVME/MA NaOH neutralised system along with 25% and 30% w/w 427 
PVM/MA TEA neutralised systems can be termed gels.  428 
 429 
3.4. Mucoadhesion of PMVE/MA Gels 430 
The effects of polymer concentration and neutralisation/type of neutralising agent on 431 
the mucoadhesive properties are presented in Table 3.  The mucoadhesive method 432 
employed in this study has been frequently reported and is accepted as a model 433 
which reliably characterises the interaction between mucin and polymeric 434 
platforms[9, 50, 51].  One benefit of this test is the ability to quantify the force (or 435 
work) required to break the adhesive bond between the polymer platform and the 436 
mucin substrate and therefore the mucoadhesive properties of polymeric platforms 437 
may be effectively compared.   Polymer concentration and neutralisation/neutraliser 438 
type significantly affected mucoadhesion, with a statistical interaction between 439 
concentration and neutraliser being identified.  In this, the dependency of polymer 440 
concentration on mucoadhesion was greater for TEA neutralised systems than for 441 
NaOH neutralised systems.  The mucoadhesive properties of un-neutralised 442 
PMVE/MA systems could not be measured using this technique however, given the 443 
ability of the method to reliably measure forces of detachment that are relevant to in 444 
vivo retention of dosage forms[29, 52, 53], it may be inferred that the mucoadhesive 445 
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properties of these systems are negligible.  The mucoadhesive properties of 446 
PMVE/MA systems significantly increased with increasing polymer concentration 447 
and were greater for TEA-neutralised gels than for their NaOH-neutralised 448 
counterparts.  The mucoadhesive properties of neutralised PMVE/MA gels (15-30% 449 
w/w) were substantial and greatly exceeded those of mucoadhesive implants that 450 
have reported to be successfully retained in vivo within the periodontal pocket[29].  451 
Furthermore, given the wide range of polymer concentrations associated with these 452 
enhanced mucoadhesive properties, it is expected that the retention of formulations 453 
in vivo, e.g. within the periodontal pocket, would be resistant to dilution from 454 
biological fluids.  Given both the wide range of concentrations that exhibited 455 
mucoadhesive properties and the magnitudes of mucoadhesion exhibited, these 456 
mono-polymeric platforms would the expected to offer prolonged retention in vivo.  457 
This is the first report that suggests this role for mono-polymeric PMVE/MA 458 
platforms. 459 
 460 
3.4. Statistical Modelling of the Relationship between Mucoadhesion and 461 
Rheological Properties of PMVE/MA Gels 462 
Within this study a series of statistical methods has been employed to ensure that 463 
the effects of primary factors on the various rheological properties were fully 464 
ascertained within a factorial experimental design. However, importantly, this study 465 
additionally examined statistical interactions between the primary factors and 466 
explained these within the context of the physicochemical properties of the gel 467 
platforms.  In so doing, a unique insight into the polymer state was derived.  A key 468 
task of this manuscript was to understand the relationship between the various 469 
polymeric variables and mucoadhesion, a relationship that has not been fully 470 
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described in the scientific literature to date.  This study therefore described the 471 
application of multiple linear regression to model the relationships between the 472 
various variables with mucoadhesion, a parameter that is indicative of retention in 473 
vivo.  Accordingly, using a general linear model three major variables were observed 474 
to affect mucoadhesion, namely polymer concentration, pH and the type of 475 
neutralising agent.  There were strong statistical interactions between these 476 
variables and their effects on mucoadhesion.  In these, the effect of polymer 477 
concentration on mucoadhesion was significantly greater in gels neutralised with 478 
TEA than in gels neutralised using NaOH.  Similarly there was an interaction 479 
between the pH and polymer concentration on mucoadhesion in which polymer 480 
concentration exhibited a significantly greater effect on the mucoadhesion of 481 
PMVE/MA gels when neutralised.  To understand these relationships further 482 
stepwise multiple regression analysis between the viscoelastic parameters and 483 
mucoadhesion was performed.  Unsurprisingly, the correlation matrix identified 484 
strong relationships between the various viscoelastic properties and therefore the 485 
multiple regression analysis was simplified by considering the effect of storage 486 
modulus on the mucoadhesive properties of neutralised PMVE/MA platforms over a 487 
range of different oscillatory frequencies.  At each frequency examined there was a 488 
strong relationship between storage modulus and mucoadhesion (r>0.98).  489 
Furthermore the relationship between polymer concentration and mucoadhesion 490 
was linear (r>0.99 for TEA neutralised gels, r>0.98 for NaOH neutralised gels and 491 
0.94 for the overall effect combining both types of neutralisation).  These results 492 
have enabled a re-imagination of the roles of polymer viscoelasticity, concentration 493 
and neutralisation on mucoadhesion.  The process of mucoadhesion is understood 494 
to be complex, with a number of physicochemical properties being reported to 495 
contribute to this phenomenon including polymer molecular weight, polymer 496 
conformation, degree of cross-linking, the contribution of functional groups on the 497 
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polymer and the charge on these groups[9, 54].  In this study the contribution of 498 
polymer molecular weight and the type of functional group were constant across all 499 
polymer platforms; however, the contributions of charge on the groups and polymer 500 
concentration on mucoadhesion may be considered.  Interestingly, there has been 501 
little attention paid to the relationships between the aforementioned properties, 502 
polymer viscoelasticity and mucoadhesion.  This study has addressed this paucity 503 
of information.  Mucoadhesion involves an adhesive interaction between a polymeric 504 
platform and mucin, facilitated through specific (hydrogen) bond formation[9].  In 505 
principal, this interaction should be enhanced whenever the functional groups in 506 
both polymers are unionised however this study has clearly shown that ionisation, 507 
facilitated through neutralisation of the carboxylate groups of PMVE/MA resulted in 508 
both marked and enhanced mucoadhesion.  Notably, whilst the degree of polymer 509 
ionisation affected mucoadhesion, the contribution of polymer viscoelasticity was 510 
dominant, as defined within the statistical model.  Thus, at identical levels of 511 
ionisation the role of neutralising agent on the mucoadhesive and viscoelastic 512 
properties was significant. Neutralisation with TEA resulted in a greater expansion of 513 
the polymer chains through charge repulsion than in platforms similarly neutralised 514 
using NaOH; the difference being accredited to charge shielding of the ionised 515 
carboxylate groups with the sodium counterion.  At pH 7.4 the degree of ionisation 516 
of PMVE/MA was circa 99% and therefore, whilst there were differences in shielding 517 
of charge in the two neutralised, both systems exhibited predominantly anionic 518 
properties.  With reference to the observed (strong) correlations between polymer 519 
viscoelasticity and mucoadhesion, this study has highlighted that the dominant 520 
factor that contributes to mucoadhesion is polymer viscoelasticity.  Thus, as the 521 
elastic properties of PMVE/MA are increased, the mucoadhesion increased, notably 522 
in a linear fashion.  Whilst not observed in this study, an upper limit in PMVE/MA 523 
concentration would be expected beyond which no further increase in 524 
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mucoadhesion is observed.  In this scenario, the polymer interactions within 525 
PMVE/MA would predominate thereby reducing the likelihood of adhesive 526 
interactions with mucin.    It should be clearly stated that, through the application of 527 
statistical modelling, this study has clearly defined the dominant role of polymer 528 
viscoelasticity on mucoadhesion, a conclusion that has not been directly defined in 529 
previous studies.  These observations explain, at least in part, the mucoadhesive 530 
properties of non-charged polymers, e.g. cellulose ethers[9]. 531 
 532 
3.5. Re-defining the clinical opportunities for PMVE/MA Gels 533 
Despite the use of PMVE/MA as a component within mucoadhesive platforms, there 534 
has been limited use of this polymer as a single component system.  Historically, 535 
this may be related, at least in part, to the limited viscosity enhancement per unit 536 
mass of polymer associated with this polymer (and the associated commercial cost). 537 
Alteration of the concentration of PMVE/MA and/or neutralisation enhanced the 538 
viscoelastic properties of the polymer platform and, in so doing, facilitated 539 
enhanced mucoadhesion.  Within the clinical domain, it is important that the 540 
administration of implants is both not compromised by viscosity (associated with 541 
increased polymer concentration) and is retained at the proposed site of 542 
administration, the latter being facilitated by enhanced viscoelasticity (and polymer 543 
concentration).  Therefore a compromise is required between these two phenomena.  544 
There is published evidence that clarifies the key rheological properties of gel 545 
systems that have been successfully employed in vivo as implants for the treatment 546 
of oral diseases, a potential application for the PMVE/MA systems under current 547 
examination[29, 53, 55].  For example in these systems the storage modulus (at 548 
circa 10Hz) and zero shear rate viscosity of a platform that was successfully applied 549 
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to and retained within the periodontal pocket using a periodontal syringe were circa 550 
3.5kPa and 2.6kPa.s, respectively.  Accordingly, PVME/MA 30% w/w, TEA 551 
neutralised gels, despite their excellent mucoadhesive properties would be 552 
inappropriate for delivery using a periodontal syringe, however in applications 553 
involving application of the gel to the site of action directly from a standard 554 
container (e.g. using an applicator or manually), this would not be as important. It 555 
should be noted that the rheological and mucoadhesive properties of the polymeric 556 
platforms described in this study would be suitable for other pharmaceutical and 557 
biomedical applications.  For example, modification of the polymer concentration 558 
will enable the rheological and mucoadhesive properties of PMVE/MA gels to be 559 
engineered that are suitable for use as ophthalmic viscosurgical devices during 560 
phacoemulsification[19] or for vaginal drug delivery applications[51].  Finally, it is 561 
important to reiterate that by selection of polymer concentration and neutraliser type, 562 
PMVE/MA gels may be prepared that offer comparable rheological and 563 
mucoadhesive properties to multicomponent polymeric platforms that have been 564 
successful clinically [29, 53].  This is important as it will obviate potential issues with 565 
rheological ageing (structuring or destructuring) upon storage of multicomponent 566 
systems.   567 
 568 
4. Conclusions 569 
In this study the rheological and mucoadhesive properties of aqueous PMVE/MA 570 
platforms have been comprehensively characterised to establish their potential 571 
suitability for biomedical and pharmaceutical applications.  To address this issue, 572 
the contributions of polymer concentration, pH and type of neutralising agent to the 573 
viscoelastic and mucoadhesive properties were statistically modelled.  The 574 
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application of multiple linear regression analysis enabled the specific relationships 575 
between the viscoelastic and mucoadhesive properties to be explicitly defined, a 576 
feature that has yet to receive sufficient attention within the scientific literature.  This 577 
study uniquely identified the dominant contribution of polymer viscoelasticity on 578 
mucoadhesion, an outcome that may be employed to rationally design 579 
mucoadhesive platforms.  Manipulation of both the rheological (flow and oscillatory 580 
rheometry) and mucoadhesive properties was performed by changing both polymer 581 
concentration and pH and by choice of neutralising agent.  In so doing mono-582 
polymeric PMVE/MA platforms were prepared that, based on previous reports 583 
offered wide ranges of rheological and mucoadhesive properties that rendered them 584 
suitable for a range of pharmaceutical and biomedical properties where prolonged 585 
retention at the site of application is required.  586 
  587 
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Legends for Figures 588 
Figure 1a. Huggins plot illustrating the relationship between reduced viscosity 589 
and concentration of PMVE/MA.  Circles refer to Unneutralised PMVE/MA whereas 590 
squares and triangles refer to PMVE/MA that had been neutralised using either 591 
NaOH or TEA, respectively.  Standard deviations from five replicate measurements 592 
are included. 593 
 594 
Figure 1b. Fuoss and Strauss plot illustrating the relationship between log 595 
reduced viscosity and the square root of concentration of PMVE/MA.  Circles refer 596 
to Unneutralised PMVE/MA whereas squares and triangles refer to PMVE/MA that 597 
had been neutralised using either NaOH or TEA, respectively.  Standard deviations 598 
from five replicate measurements are included. 599 
 600 
Figure 2. The relationship between modulus (storage and loss) and frequency 601 
for unneutralised PMVE/MA platforms.  Figure 2(a) relates to PMVE/MA 5% w/w 602 
(circles), PMVE/MA 10% w/w (squares) and PMVE/MA 15% w/w (diamonds).  Figure 603 
2(b) relates to PMVE/MA 20% w/w (circles), PMVE/MA 25% w/w (squares) and 604 
PMVE/MA 30% w/w (diamonds).  Closed symbols relate to the storage modulus 605 
whereas open symbols refer to the loss modulus.  Standard deviations from five 606 
replicate measurements are included. 607 
 608 
 609 
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Figure 3. The relationship between modulus (storage and loss) and frequency 610 
for PMVE/MA platforms that have been neutralised using NaOH.  Figure 3(a) relates 611 
to PMVE/MA 5% w/w (circles), PMVE/MA 10% w/w (squares) and PMVE/MA 15% 612 
w/w (diamonds).  Figure 3(b) relates to PMVE/MA 20% w/w (circles), PMVE/MA 25% 613 
w/w (squares) and PMVE/MA 30% w/w (diamonds).  Closed symbols relate to the 614 
storage modulus whereas open symbols refer to the loss modulus.  Standard 615 
deviations from five replicate measurements are included. 616 
 617 
Figure 4. The relationship between modulus (storage and loss) and frequency 618 
for PMVE/MA platforms that have been neutralised using triethylamine.  Figure 4(a) 619 
relates to PMVE/MA 5% w/w (circles), PMVE/MA 10% w/w (squares) and PMVE/MA 620 
15% w/w (diamonds).  Figure 4(b) relates to PMVE/MA 20% w/w (circles), PMVE/MA 621 
25% w/w (squares) and PMVE/MA 30% w/w (diamonds).  Closed symbols relate to 622 
the storage modulus whereas open symbols refer to the loss modulus.  Standard 623 
deviations from five replicate measurements are included. 624 
 625 
 626 
 627 
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Table 1. The effects of polymer concentration, neutralising agent and oscillatory frequency on the loss tangent (tan δ) and dynamic 
viscosity (η’) of aqueous poly(methylvinyl ether-co-maleic acid) platforms 
Concentration of 
PMVE/VA (% w/w) 
Neutralisation Mean (± sd) Consistency 
(Pa.s)n 
Mean (± sd) Rate Index Mean (± sd) zero shear 
rate viscosity (Pa.s) 
5 Un-neutralised 0.02 ± 0.00 0.98 ± 0.00 0.02 ± 0.00 
10 Un-neutralised 0.25 ± 0.02 0.92 ± 0.02 0.20 ± 0.02 
15 Un-neutralised 1.36 ± 0.03 0.87 ± 0.01 0.97 ± 0.05 
20 Un-neutralised 6.21 ± 0.39 0.82 ± 0.01 4.37 ± 0.28 
25 Un-neutralised 35.73 ± 0.70 0.67 ± 0.01 23.66 ± 0.12 
30 Un-neutralised 105.80 ± 5.34 0.60 ± 0.01 89.41 ± 4.02 
5 Neutralised with NaOH 0.96 ± 0.05 0.88 ± 0.01 0.76 ± 0.05 
10 Neutralised with NaOH 5.23 ± 0.44 0.84 ± 0.00 4.52 ± 0.43 
15 Neutralised with NaOH 35.48 ± 2.39 0.81 ± 0.00 43.76 ± 2.57 
20 Neutralised with NaOH 133.93 ± 8.19 0.71 ± 0.03 207.70 ± 11.33 
25 Neutralised with NaOH 510.10 ± 9.20 0.59 ± 0.00 992.97 ± 11.22 
30 Neutralised with NaOH 1928.00 ± 73.70 0.57 ± 0.00 5548.33 ±  153.08 
5 Neutralised with TEA 3.26 ± 0.03 0.85 ± 0.01 1.97 ± 0.09 
10 Neutralised with TEA 19.86 ± 0.73 0.81 ± 0.01 21.39 ±1.18 
15 Neutralised with TEA 109.53 ± 3.54 0.74 ± 0.01 159.90 ± 7.55 
20 Neutralised with TEA 384.30 ± 5.15 0.59 ± 0.01 886.37 ± 54.38 
25 Neutralised with TEA 1191.00 ± 11.53 0.53 ± 0.00 3397.67 ± 80.21 
30 Neutralised with TEA 2471.00 ± 95.17 0.47 ± 0.01 13720.00 ± 469.36 
  
Table 2. The effects of polymer concentration, neutralising agent and oscillatory frequency on the loss tangent (tan δ) and dynamic 
viscosity (η’) of aqueous poly(methylvinyl ether-co-maleic acid) platforms 
PMVE/MA 
Concetration 
Oscilatory 
Frequency (Hz) 
Mean (± standard deviation) viscoelastic parameters 
Unneutralised Neutralised (pH 7.4) with NaOH Neutralised (pH 7.4) with 
Triethylamine 
tan δ η’ (Pa.s) tan δ η’ (Pa.s) tan δ η’ (Pa.s) 
5 2.37 NM* NM* 4.19 ± 0.28 0.57 ± 0.02 2.94 ± 0.05 1.05 ± 0.01 
5.39 NM* NM* 2.82 ± 0.20 0.50 ± 0.02 2.18 ± 0.03 0.84 ± 0.01 
9.99 NM* NM* 2.01 ± 0.20 0.43 ± 0.01 1.75 ± 0.10 0.68 ± 0.02 
10 2.37 NM* NM* 2.54 ± 0.07 2.58 ± 0.03 1.68 ± 0.01 5.88 ± 0.34 
5.39 NM* NM* 1.93 ± 0.03 2.03 ± 0.03 1.37 ± 0.01 4.15 ± 0.14 
9.99 NM* NM* 1.60 ± 0.04 1.62 ± 0.03 1.18 ± 0.01 3.02 ± 0.11 
15 2.37 5.60 ± 0.70 0.85 ± 0.02 1.68  ± 0.01 11.77 ± 0.13 1.17 ± 0.00 25.33 ± 0.12 
5.39 3.57 ± 0.12 0.74 ± 0.01 1.37 ± 0.01 8.23 ± 0.09 0.99 ± 0.00 16.02 ± 0.10 
9.99 2.62 ± 0.07 0.67 ± 0.01 1.18 ± 0.01 6.09 ± 0.07 0.88 ± 0.00 11.01 ± 0.05 
20 2.37 3.00 ± 0.13 2.90 ± 0.16 1.15 ± 0.04 34.35 ± 0.51 0.90 ± 0.00 62.06 ± 0.37 
5.39 2.17 ± 0.08 2.37 ± 0.12 0.98 ± 0.03 21.81 ± 0.14 0.77 ± 0.00 36.24 ± 0.19 
9.99 1.73 ± 0.07 1.97 ± 0.09 0.86 ±0.02 15.02 ± 0.02 0.68 ± 0.00 23.50 ± 0.11 
25 2.37 1.95 ± 0.01 11.38 ± 0.15 0.92 ± 0.00 83.15 ± 0.68 0.72 ± 0.00 129.90 ± 1.57 
5.39 1.57 ± 0.01 8.30 ± 0.11 0.79 ± 0.00 48.53 ± 0.29 0.63 ± 0.00 71.00 ± 0.80 
9.99 1.35 ± 0.01 6.35 ± 0.10 0.71 ± 0.00 31.60 ± 0.11 0.56 ± 0.00 44.22 ± 0.46 
30 2.37 1.51 ± 0.02 25.53 ± 1.12 0.70 ± 0.01 173.90 ± 3.41 0.62 ± 0.01 212.03 ± 5.00 
5.39 1.25 ± 0.02 17.38 ± 0.74 0.61 ± 0.01 94.17 ± 1.50 0.54 ± 0.01 111.17 ± 2.34 
9.99 1.09 ± 0.01 12.66 ± 0.53 0.55 ± 0.01 58.21 ± 0.87 0.49 ± 0.01 67.53 ± 1.29 
* Not Measureable 
Table 3. The effects of polymer concentration, neutralising agent and oscillatory frequency on the loss tangent (tan δ), dynamic viscosity 
(η’) and mucoadhesion of aqueous poly(methylvinyl ether-co-maleic acid) platforms 
PVME/MA 
Concentration (% 
w/w) 
Neutralisation Mean (± sd) Gel 
Strength (Pa) 
Mean (± sd) 
Rheological 
Exponent 
Crossover Frequency 
(Hz) 
Mean (± sd) 
Mucoadhesive Bond 
Strength (N) 
5 Unneutralised Not Measureable Not Measureable Not Observed* Not Measureable 
 NaOH 0.61 ± 0.13 1.35 ± 0.08 Not Observed* Not Measureable 
 Triethylamine 1.53 ± 0.08 1.27 ± 0.03 Not Observed* Not Measureable 
10 Unneutralised Not Measureable Not Measureable Not Observed* Not Measureable 
 NaOH 4.62 ± 0.34 1.20 ± 0.03 Not Observed* Not Measureable 
 Triethylamine 19.42 ± 0.88 0.98 ± 0.00 Not Observed* Not Measureable 
15 Unneutralised 0.40 ± 0.09 1.72 ± 0.11 Not Observed* Not Measureable 
 NaOH 35.14 ± 0.90 1.04 ± 0.01 Not Observed* 0.54 ± 0.05 
 Triethylamine 150.14 ± 0.72 0.76 ± 0.00 5.18 ± 0.03 0.70 ± 0.04 
20 Unneutralised 3.50 ± 0.37 1.40 ± 0.02 Not Observed* Not Measureable 
 NaOH 213.10 ± 15.12 0.75 ± 0.02 5.12 ± 0.12 0.70 ± 0.03 
 Triethylamine 547.52 ± 4.70 0.63 ± 0.00 1.34 ± 0.02 0.85 ± 0.04 
25 Unneutralised 28.86 ± 0.70 1.08 ± 0.01 Not Observed* 0.12 ± 0.01 
 NaOH 732.59 ± 10.26 0.62 ± 0.00 1.48 ± 0.03 1.02 ± 0.05 
 Triethylamine 1596.97 ± 26.10 0.52 ± 0.00 0.37 ± 0.01 1.20 ± 0.04 
30 Unneutralised 94.31 ± 5.70 0.96 ± 0.01 Not Observed* 0.21 ± 0.02 
 NaOH 2322.43 ± 77.44 0.48 ± 0.00 0.24 ± 0.02 1.27 ± 0.04 
 Triethylamine 3152.17 ± 145.75 0.47 ± 0.01 0.20 ± 0.01 1.58 ± 0.02 
* Not observed over the frequency range studied 
 
